BELS Springboard, Sustaining, Charter & Founding Members

BELS is pleased to introduce new categories of membership –Sustaining, Charter, and Springboard — for people who wish to support the organisation at a higher level, to help us accelerate our progress.

BELS Sustaining Members

BELS gratefully acknowledges our Sustaining Members who generously support BELS, a recently-added membership category. The investment by BELS Charter Members in the organisation helps to support the planning and delivery of BELS activities and to extend the UK’s heritage of scientific excellence in the spirit of collaboration, innovation and kinship.

Mark Bamforth, President & CEO, Arranta Bio, Cambridge MA

 

BELS Founding Members

BELS gratefully acknowledges our early Founding Members who generously supported BELS financially to help us re-launch BELS globally in 2016. Their contributions have helped extend the UK’s heritage of scientific excellence in the spirit of collaboration, innovation and kinship.

Mark Bamforth, President & CEO, Arranta Bio, Cambridge MA

Dr Dominic P Behan, President & CEO, Sentia Medical Sciences, San Diego CA

Dr Simon Blake, Sr Director, Scientific Licensing, Immunology, Janssen Research & Development, Berwyn PA

Dr Timothy P Clackson, President & EVP R&D – Xilio Therapeutics, Cambridge MA

Nicola Downes, Chief Financial Officer, uLab Systems, Redwood City CA

Dr David R Ebsworth, Chairman, Verona Pharma and Actimed Therapeutics, Switzerland

Dr Christopher H Evans, Professor & Director of Rehabilitation Medicine Research Center, Mayo Clinic, Rochester MN

Dr Clive A Meanwell, Ex Chief Executive Officer, The Medicines Company, Parsippany NJ

Dr Stephen Naylor, Chairman & CEO, MaiHealth, Indianapolis IN